None listed
Conditions
Brief summary
A randomised cross-over feeding study conducted in free-living adults (aged 18 years and older) with high blood pressure and type 2 diabetes or pre-diabetes living in the local Hunter region. Participants will be enrolled in an 8-week dietary intervention consisting of a 2-week run-in period (habitual/usual diet) followed by 2 x 2-week dietary intervention periods that include a 2-week washout between them. The 2-week diet periods will consist of a ‘Healthy Australian Diet’ (HAD) and the “Healthy Australian Dietary pattern + bioactive foods” (HAD+). The HAD+ will have foods from the 5 core food groups from the current Australian Dietary Guidelines for adults with the addition of high bioactive foods that have been associated with reducing BP. The key foods in the HAD+ diet will include oats, beetroot, leafy green vegetables, flaxseeds, citrus fruit, and mixed nuts. These two diets will be allocated in a randomised order. During the 2-week washout period the participant returns to their / usual diet). The entirety of the diet (i.e., 3 main meals and snacks per day) will be provided to participants during dietary period 1 and 2. Participants will supply their own meals and foods during the run-in and washout periods. Study participation involves completing self-administered questionnaires (e.g., food frequency, health, demographic, physical activity questionnaire); collection of biosamples (fasted blood sample, urine and faecal sample) and physical measurements such as blood pressure, arterial stiffness, anthropometry and body composition.
Interventions
Eight-week dietary intervention consisting of a 2-week run-in period (habitual/usual diet) followed by dietary pattern 1 for 2 weeks, 2-week washout period (habitual/usual diet), then lastly dietary pattern 2 for 2 weeks in a randomised order. The entirety of the diet (i.e., 3 main meals and snacks per day) will be provided to participants during dietary phase 1 and 2. Participants will supply their own meals and foods during the run-in and washout periods. Participants will be instructed to return to and maintain their habitual diet in the run-in and washout period, with adherence to this assessed with 2x 24 hour recalls at each timepoint including washout and run-in periods. The two dietary phases will consist of a “healthy Australian dietary pattern + bioactive foods” (HAD+) and a “healthy Australian dietary pattern” (HAD) that will be matched to participant’s usual caloric intake as assessed during the run-in period. Both the HAD+ and HAD will be matched for their sodium and potassium intakes to ensure this does not confound blood pressure (BP) responses. Energy, sodium and potassium for each diet was created using Foodworks. Dietary intake and compliance will be checked using 24 hour food recalls and spot urine samples. The HAD+ will have foods from the 5 core food groups from the current Australian Dietary Guidelines for adults with the addition of high bioactive foods that have been associated with reducing BP. The diet aims to meet the Acceptable Macronutrient Distribution Ranges (AMDR) e.g., 15-25% energy from protein, 45-65% energy from carbohydrates, 20-35% energy from fat; less than or equal to 10% energy from saturated fat and less than or equal to 1% energy from trans fat. Fibre intake may exceed the 25-30g/day recommendation due to the focus on soluble fibres. Sodium/potassium ratio will be matched with the HAD+ and the HAD plan. Nitrate rich vegetables are also included in this diet. The key foods in the HAD+ diet will include oats, beetroot, leafy green vegetables, flaxseeds, citrus fruit, and mixed nuts. All meals and snacks are provided to participants for the duration of both 2-week diet intervention phases. This includes pre-prepared main meals (e.g., ready made fresh meals or frozen meals), fresh produce, cereals and snacks. Study investigators calorie-match the foods (to the participants baseline usual calorie intake) to be provided which are placed as a grocery order by the study investigators during the appointment with the participants at the preceding phase. Participants collect the pre-ordered and pre-paid grocery items at their nearest allocated supermarket chain or via home delivery. The dietary intervention has been designed by and will be monitored by study coordinators who are also accredited practising dietitians. Participants are instructed to avoid consuming non-study foods, with usual beverage intake permitted except for discretionary choice beverages. Adherence to protocol will be examined during the 2-week run-in & washout periods prior to the feeding interventions and will be reassessed throughout the feeding intervention periods. Participants who do not meet adherence guidelines during the run-in period will be withdrawn from the study prior to randomisation. Adherence measures during the run-in period will include: • Collection of two 24-hour recalls • Record keeping of habitual consumption of tea, coffee, and alcohol (using Easy Diet Diary app or written food record as per participant preference) • Record keeping of any food consumed out of the home e.g., takeaway, restaurant / café foods (using Easy Diet Diary app or written food record) • Completion of one AES®-Heart survey • Collection of each biospecimen: urine, blood and faecal samples • Completion of one 24-hour ambulatory BP monitoring After completion of each dietary intervention phase, participants undergo a 2-week washout period where they return to their usual food habits, eating their own food (i.e., no food is supplied during the washout period). Upon enrolment, consent participants commence a 2-week run-in period prior to their first diet allocation. During the run-in period where they continue to consume their habitual diet (note, food is not supplied by study investigators for the run-in period). The run-in period includes collection of baseline data.
Sponsors
Study design
Eligibility
Inclusion criteria
• Adults 18 years or older with high blood pressure and T2DM • Living within 50km of Newcastle (postcode 2300) • Hypertension diagnosis verified by doctor/healthcare professional or use of anti-hypertensive medications(1) • Type 2 diabetes or pre-diabetes o Type 2 diabetes diagnosis verified by NDSS number, doctor/healthcare professional, use of oral hypoglycaemic medications, insulin(2, 3) or verification of impaired fasting glucose greater than 7.0mmol/L if not medicated or HbA1c of greater than or equal to 6.5%(4) o Pre-diabetes diagnosis verified by doctor/healthcare professional, HbA1c 6.0-6.4%, impaired fasting glucose (6.1-6.9mmol/L) or impaired glucose tolerance based on oral glucose tolerance test (fasting blood glucose less than 7.0mmol/L AND 2-hour blood glucose greater than or equal to 7.8 and less than 11.1mmol/L)(4) • Willing to adhere to strict diet protocol for 8 weeks • Willing to wear a 24-hour blood pressure cuff for 4 days throughout the 8-week study period • Access to a smart phone or tablet with access to the internet • In the Newcastle region for at least the entirety of the two feeding intervention periods • Willing to come to the University of Newcastle for data collection appointments before and after each feeding phase • Those who take vitamin and mineral supplements will be included if the trial if doses can be kept consistent throughout the 8-week trial period.
Exclusion criteria
• Any food allergies or intolerances • Those receiving cancer treatment • Those with stage 3b to stage 5 chronic kidney disease (estimated glomerular filtration rate less than 44mL/min) • People who follow a specific diet (e.g. Vegan or vegetarians) • Non-compliance during the 2-week run-in period • Individuals who have lost or gained greater than or equal to 5% body weight in the past 2 months • History of gastric ulcers, gastrointestinal disorders including severe digestive disorders such as irritable bowel syndrome • On medications known to influence study outcomes e.g. antibiotics, probiotics or prebiotics, hormone therapy, anti-inflammatory medications, corticosteroids, medications affecting metabolism • Have used antibiotics in the past 3 months • Currently using GLP-1 agonists such as semaglutide (Ozempic), dulaglutide (Trulicity), liraglutide (Victoza); or tirzepatide (Mounjaro) • On unstable medication regimen or have had blood pressure or diabetes medication changes (including dose) in the past 6 weeks. • Currently participating in another research intervention trial involving dietary intervention and/or physical activity intervention • Pregnant or breastfeeding